Results of a study done at Cedars-Sinai Medical Center in Los Angeles and Brigham and Women's Hospital in Boston suggest that older patients with low medication adherence and literacy might benefit from a pharmacist-led medication management as they are leaving the hospital.
Jefferson health and Ipendence Blue Cross are working together to improve early dementia detection and care coordination in primary care, helping patients receive support sooner and stay healthier at home
Eli Lilly's once-daily oral GLP-1, orforglipron, awaits FDA approval in April 2026. New research shows orforglipron outperforms oral semaglutide for lowering A1C and for weight loss.
Pharmacists have the training and are employed by the health system so it makes sense to put them in charge of postdischarge medication planning and management
Joshua M. Pevnick, M.D., M.S.H.S., discusses medications and the risk of an adverse drug event among older people after they get discharged from the hospital.
A childhood teacher once told Rachel Moseley, Ph.D., there was “no point” in teaching her math. Since then, she has graduated from Cambridge University in England with a doctorate in cognitive neuroscience. She and a colleague have recently published a book of interviews exploring menopause among people with autism.
UnitedHealthcare is expanding access to doula services through eligible employer-sponsored plans, aiming to improve maternal health outcomes and provide more comprehensive pregnancy support.
This FAQ outlines what managed care leaders need to know about emerging oral GLP-1 therapies, including their clinical uses, growing demand and potential impact on healthcare costs and coverage.
More than half of people in a recent survey said they find it difficult to find the lowest-cost option for their medications, and they don’t trust that they are paying the lowest price.
Chronic back pain amplifies sound unpleasantness; fMRI links it to sensory circuits, and pain reprocessing therapy may help normalize responses.
Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary cholangitis.
Findings published In JAMA Oncolog sound a note of caution about repurposing drugs for one type of cancer to another based on biomarkers alone.
In this conversation, Kirk Grisham, M.P.H., and Vishakh Unnikrishnan, M.P.H., both from the Center for HIV and Infectious Disease Policy at the O’Neill Institute, explain how federal funding cuts are destabilizing state HIV programs and why state leadership and political will now largely determine whether people keep access to HIV prevention and care.
CLDN18.2-high gastroesophageal cancer appears more common and could predict a stronger HER2 therapy benefit but a weaker immunotherapy response.
NCQA and other groups are developing a HEDIS measure of follow-up after a positive screening test. Meanwhile, a Harris survey shows public support for colorectal screening that would involve just a blood test.
The updated guidance emphasizes earlier intervention through lifestyle changes, expanded cholesterol testing including Lp(a) and coronary artery calcium scoring, and earlier use of medication.
Results of a pragmatic clinical trial showed no statistical difference between a pharmacist-led intervention and usual care when it comes to hospital utilization. The results suggest targeting such efforts at a narrower group of patients with low medication adherence and literacy might be more effective.
The Department of Health and Human Services is celebrating Match Day early by providing more than $5 million in funding to Teaching Health Center Graduate Medical Education programs, supporting approximately 100 residents training in underserved and rural communities.
IBX and Jefferson target earlier dementia diagnosis, support caregivers and use AI data to keep patients safely at home and cut costs in new dementia care program.
The FDA has approved Icotyde as the first and only IL-23R targeted oral peptide for the treatment of moderate-to-severe plaque psoriasis.
A retrospective study found similar survival outcomes whether immunotherapy was started with the first chemotherapy cycle or delayed to later cycles in patients with extensive-stage small cell lung cancer.
In Florida, abrupt cuts to HIV medication and insurance support are forcing patients off trusted regimens, exposing dangerous coverage gaps, and illustrating how policy decisions can quietly drive up both human and financial costs in the U.S. healthcare system.
Prime Therapeutics’ IntegratedRx gives prescribers and pharmacists a shared, real-time view of patient records, improving patients’ experience and better outcomes.
Researchers found that patients who had a prescription sent to an outside pharmacy had 60% higher odds of not picking up a prescription.
A new research review suggests menopause may worsen obsessive-compulsive disorder symptoms for some women, with more than a quarter reporting increased severity during the transition.
Nearly half of trial participants reported significant fear of melanoma recurrence, especially women, younger patients, and those with higher anxiety or depression.
Advocate Health, Tenet Health, Mass General Brigham, Trinity Health and the Mayo Clinic are among the hospital and health system organizations that spent more than $1 million on federal government lobbying in 2024, according to study published in JAMA Health Forum.
Utah's Office of Artificial Intelligence Policy has approved demonstration projects testing AI for prescription drug renewals and certain dental diagnoses.
